Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire November 8, 2024

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

GlobeNewswire November 4, 2024

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

GlobeNewswire October 30, 2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

GlobeNewswire October 25, 2024

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

GlobeNewswire October 24, 2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

GlobeNewswire September 26, 2024

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

GlobeNewswire September 16, 2024

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

GlobeNewswire September 16, 2024

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

GlobeNewswire September 13, 2024

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

GlobeNewswire September 11, 2024

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

GlobeNewswire September 10, 2024

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers' Option to Purchase Additional Notes

GlobeNewswire August 13, 2024

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

GlobeNewswire August 7, 2024

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

GlobeNewswire August 7, 2024

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire August 6, 2024

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET

GlobeNewswire July 31, 2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

GlobeNewswire July 15, 2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

GlobeNewswire July 2, 2024

ANI Pharmaceuticals' CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

GlobeNewswire June 25, 2024

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

GlobeNewswire June 24, 2024